adrenoleukodystrophy; adenosine 5Ј-triphosphate-binding cassette transporters; peroxisome; polyunsaturated fatty acid; docosahexanoic acid PEROXISOMES ARE SUBCELLULAR organelles ubiquitously expressed (8) . Although originally believed to be autonomous organelles like mitochondria, recent data (21, 55) on the ontogenetic and evolutionary origin of peroxisomes have suggested otherwise, with peroxisomes being derived from the endoplasmic reticulum. Peroxisomes are indispensable for development, morphogenesis, and differentiation, and they play key roles in hydrogen peroxide detoxification and lipid metabolism. In mammals, peroxisomes are involved in the degradation of purines, polyamines, and amino acids; the biosynthesis of ether phospholipids and bile acids; and fatty acid ␣-and ␤-oxidation (67) . The peroxisomal oxidation machinery is not able to degrade fatty acyl-CoAs to completion; the chainshortened acyl-CoAs are shuttled to mitochondria to complete their degradation to CO 2 and H 2 O via Krebs cycle. Defects of peroxisomal fatty acid oxidation are associated with a range of severe human disorders (66) . The same peroxisomal ␤-oxidation machinery is used for the degradation of saturated and monounsaturated VLCFA and for the biosynthesis of bile acids and polyunsaturated fatty acids (PUFA) from the 3 and 6 series, namely docosahexaenoic acid (DHA; C22:63) and docosapentaenoic acid (DPA; C22:56; Refs. 11, 40, 59) . DHA is the predominant 3-PUFA in the mammalian central nervous system, reaching up to 15% concentration of the total fatty acids in brain (51) . A growing body of evidence based on epidemiological and interventional studies shows that low levels of DHA may play a role in age-related neurodegenerative diseases and depression (30, 39, 53) . The precursors of DHA and DPA, C24:63 and C24:56, respectively, are synthesized in the endoplasmic reticulum and transported to peroxisomes, where they must be imported across the membrane to undergo shortening via ␤-oxidation in the peroxisomal matrix (59) . Four ATP-binding cassette transporters (ABC transporters) have been identified at the peroxisomal membrane in mammals (ABCD1 to ABCD4 genes, encoding homonymous proteins). Rather than being full transporters such as cystic fibrosis transmembrane regulator (CFTR, ABCC7) or the multidrug resistance gene (MDR1, ABCB1), the peroxisomal ABCDs are half-size transporters and need to homo or heterodimerize to become functional. ABCDs are thought to be involved in the transport of fatty acids, based on three principal findings: 1) peroxisomal membranes are not freely permeable, the entrance and exit of metabolites requires the presence of peroxisomal transporter proteins; 2) the two peroxisomal ABC transporters of Saccharomyces cerevisiae, Pxa1 and Pxa2, form functional heterodimers that transports long-chain fatty acyl-CoAs into the peroxisome (20, 63) ; and 3) inactivation of ABCD1 causes the human disease X-linked adrenoleukodystrophy (X-ALD), which is biochemically characterized by the pathognomonic accumulation of saturated VLCFAs, mainly hexacosanoic acid (C26:0), in plasma and tissues. Oxidation of the VLCFA C26:0 and C24:0 is impaired in X-ALD fibroblasts, suggesting that ABCD1 is involved in the import of VLCFAs into the peroxisome for degradation (45) . Thus the observed ␤-oxidation defect must be secondary to the impaired transport of the substrate across the peroxisomal membrane in the absence of a functional transporter in these cells (20, 58, 64) . In analogy with the work in yeast, it has been postulated that ABCD1 transports the CoA esters of VLCFAs across the peroxisomal membrane in mammals (63) .
The four human ABCD transporters share a high sequence homology, suggesting similarity of function to a certain degree. ABCD2 shares 80%, ABCD3 shares 60%, and ABCD4 shares 46% of homology with ABCD1 (24, 33, 57) . The function of ABCD4 has not been studied yet; mice deficient for ABCD3 have been shown to accumulate bile acid precursors [3␣,7␣,12␤-trihydroxy-5␤-cholest-26-oic acid (THCA) and 3␣,7␣-dihydroxy-5␤-cholestan-26-oic acid (DHCA)] and pristanic acid (Wanders, R. J. A., personal communication). ABCD2 and ABCD3 can compensate for ␤-oxidation defects in X-ALD fibroblasts when overexpressed (42) . Recently, we (12, 47) reported a functional overlap between ABCD1 and ABCD2 transporters on the metabolism of VLCFA in vivo, as concluded from observations in mouse models in which either Abcd1 and/or Abcd2 was disrupted or overexpressed. However, the differences in sequence, expression patterns (62) , and phenotype of these mice suggest specific roles for ABCD2 in fatty acid homeostasis. Indeed, Abcd2 Ϫ/Ϫ mice exhibit a lateonset cerebellar and sensory ataxia, areflexia, loss of cerebellar Purkinje cells, and dorsal root ganglia cell degeneration (12) , together with oxidative damage in adrenal gland (35) . These pathological features, not shared with Abcd1 null mice, might indicate that substrate specificity occurs in spite of a certain degree of overlap on C26:0 and/or that expression patterns at the cellular level are different between both and so are the cell types most sensitive to demise upon loss of function (62) . In the present study, we take advantage of the available Abcd1 and Abcd2 null mice and set out to gain insight into ABCD2 biochemical roles related to peroxisomal metabolism. After comparative genomics analysis, we determined the composition of fatty acids of tissues with good expression of Abcd2, and subsequently, designed functional tests aimed to give strength to our observations, such as dietary manipulations and fasting. Of particular relevance, we set up an ex vivo peroxisomal ␤-oxidation assay, which allowed us to directly assess the role of ABCD2 and ABCD1 in fatty acid oxidation in the mouse brain.
MATERIALS AND METHODS
Comparative genomic analyses. BLAST (2) searches obtained all recognizable ABCD paralogues from 39 eukaryotic genome projects by using ENSEMBL genomes, National Center for Biotechnology Information genomes, Integr8 portal maintained by the European Bioinformatics Institute, Sanger Institute, Center for the Study of Biological Complexity, The Institute for Genomic Research, BROAD Institute, The Josephine Bay Paul Center in Comparative Molecular Biology and Evolution, Joint Genome Institute, and Cyanidioschyzon merolae Genome Project.
Multialignment and phylogenetic analyses. ABCD proteins were analyzed by ClustalX (61) and refined manually with MEGA version 3.0 (27) and GeneDOC (43) . Insertions and sequence characters not alignable with confidence and incomplete sequences were removed. The final phylogenetic alignment included 87 taxa. The phylogenetic tree was created using ProtTest (1) . ProtTest selects the most appropriate model of protein evolution among 64 different ones based on the smallest Akaike Information Criterion or Bayesian Information Criterion score. This software takes advantage of the PAL library (10) and of the Phyml program (16) . The best-fit model of protein evolution for ABCD protein family according to ProtTest corresponds to a RtREV model with invariable site parameter (ϩI), different evolution rate among sites (ϩG), and site frequencies (ϩF). The ABCD1 and ABCD2 incomplete sequences from draft genomes (for instance, Pan troglodytes, Takifugu rubripes, Tetraodon nigroviridis, and Bos taurus) have not been included for the sake of reliability of the multialignment and phylogenetic tree.
Transmembrane predictors. Secondary structure and transmembrane predictions of ABCD1 and ABCD2 were performed using PredictProtein (www.predictprotein.org; Ref. 50 ) and PHDhtm, a program to predict the location and topology of transmembrane helices from multiple sequence alignments (49) .
Mouse breeding. The genotyping of Abcd1 Ϫ and Abcd2 Ϫ/Ϫ mice has been previously described (12, 36) . To obtain double heterozygous mutants, we crossed Abcd1 null females (mutation is on the X chromosome) with Abcd2 Ϫ/Ϫ males. Double heterozygous in the F1 generation were intercrossed to obtain double knockout mice and wild-type littermate controls; the offspring obeyed Mendelian ratios. Mice used for quantitative-PCR experiments and fatty acid analysis in serum were on a pure C57BL/6J background (backcrossed at least 12 generations into C57BL/6J), whereas for the rest of experiments they were on a mixed C57BL/6J/129Sv background (ϳ87% C57BL/6J and ϳ13% 129Sv). Only male littermates were used for all the experiments. All animals were housed under the same controlled conditions between 22 and 25°C on a 12-h light-dark cycle with free access to food and water. Animals were killed, and tissues including the brain, spinal cord, sciatic nerve, adrenal gland, and liver were snap frozen in liquid nitrogen and conserved at Ϫ80°C. Fatty acid determination. Tissues from three to eight mice of each genotype were dissected and stored frozen at Ϫ80°C. After chloroform/methanol extraction (2.1, v/v), the upper phase was removed and the lower phase was dried under nitrogen and weighted for total lipid weight. A volume of 0.1 ml of lower phase fatty acids were subjected to one-step transmethylation after the Lepage and Roy method (31) , dissolved in hexane to a concentration of 0.1 g/ml, and quantified by gas-liquid chromatography. These occurred as free fatty acids in cytoplasm, as acyl-CoA fatty acids or as lateral chains of membrane complex lipids. Equipment used was a high-resolution gas chromatograph 8000 Mega series (Fisons Instruments) equipped with split/ splitless injector system and flame ionization detector. The column used was a DB-1 (Agilent Technologies; 30 m ϫ 0.25 mm) with 0.25-m film thickness for saturated fatty acids and BPX-70 (Agilent; 60 m ϫ 0.2 5 mm) with 0.25-m film thickness for monounsaturated fatty acids and PUFAs. Quantification and identification of each compound were made with the respective fatty acid methyl ester standarization curve using C19:0 and C27:0 as internal standards. Detection limit or sensitivity of the assay is 0.5 nmol. The values of each fatty acid are expressed as nanomoles per milligrams of total lipid and as percentage of total fatty acids identified in Supplemental Table 1 (supplemental data for this article are available online at the Am J Physiol Endocrinol Metab website), following the method used in Heinzer et al. (19) . For the sake of clarity, figures show the percentage of total fatty acids quantified only. We measured C16:0, C18:0, C20:0, C22:0, C24:0, C26:0, C18:1, C20:1, C22:1, C24:1, C18:2, C20:3, C20:4, C22:4, C22: 56, C18:3, C20:5, C22:5, and C22:63. Unless otherwise stated, sig-nificant differences have been determined by ANOVA followed by post hoc Tukey's honestly significantly different test (P Յ 0.05, P Յ 0.01, and P Յ 0.001) or by Wilcoxon test (P Յ 0.05).
Hippocampal-cortical primary neurons culture. Hippocampi and cerebral cortices were dissected from E16 mice embryos of pure C57BL/6J background, and the blood vessels and meninges were removed under microscope and placed in ice-cold HBSS. Tissue was incubated for 15-20 min in a solution of trypsin and DNAse I to dissociate cells, and the reactions were terminated by adding heatinactivated horse serum. Afterwards, the cell suspensions were centrifuged at 500 g and the pellet was resuspended in Neurobasal medium supplemented with L-glutamine (1 mM), the serum-free B-27 supplement from GIBCO, and 5% horse serum. Cells were plated onto poly-D-lysine-coated Petri-dishes at a seeding density of 2 ϫ 10 5 cells/cm 2 and incubated at 37°C in a humidified incubator with 5% CO 2. Three hours after being plated, the medium was replaced and horse serum was removed. After 4 days of culture, neurons were harvested and fatty acid levels were quantified.
Cortical slices preparation and peroxisomal fatty acid ␤-oxidation. The brain from 7-wk-old male mice on C57BL/6/J was immediately removed; the cortex was dissected and chopped into 350-m slices in the paraxial plane using a McIlwain tissue chopper. The resulting slices were immediately washed three times in a Grey's balanced salt solution using a modification of procedures described previously (60) . Cultures were maintained in a serum-based medium (consisting of 100 ml advanced minimum essential medium, 50 ml heat inactivated horse serum, 50 ml HBSS, 2 ml 30% glucose, and 1 ml 200 mM L-glutamine). [1- 14 C]26:0 and [1-14 C]24:63 were incubated on cortical brain slices for 3 h. C26:0 and C24:63 ␤-Oxidation was measured as previously described (65) . Activity was expressed as nanomoles of radiolabeled acetate made in 1 h per milligrams of protein. The ␤-oxidation value is expressed as percentage of activity relative to weight of four to six independent samples. Each sample has been assayed in triplicates; results shown are the pool of two independent experiments. Significant differences were determined by ANOVA followed by Tukey's honestly significantly different posttest (P Յ 0.05, P Յ 0.01, and P Յ 0.001).
Synthesis of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Table 2 ). Data are means Ϯ SE.
RESULTS
Origin of ABCD1 and ABCD2. Phylogenetic analysis of ABCD family members of 39 eukaryotic full sequenced genomes indicated that ABCD1 and ABCD2 are close paralogues that diverged rather late in evolution at the vertebrate lineage (Fig. 1) . Indeed, the ascidian Ciona intestinalis, a sea squirt and the only chordate invertebrate whose genome is available, contains only one bona fide ABCD, similar to both ABCD1 and ABCD2. The same is true for worms and insectae; only one ABCD halfway between ABCD1 and ABCD2 can be found in their genomes. Plants, here represented by Oryza sativa and Arabidopsis thaliana, do not have any ABCD1-ABCD2 homologue; their closest ABCD, the comatose protein, is more similar to ABCD3 than to ABCD1 in contrast to previous reports (13) . Fungi have two ABCD related proteins: Pxa2p and Pxa1p, which appear closer to ABCD1-2 than to ABCD3 or ABCD4, although they are more similar to one another than to any metazoan ABCD ( Fig. 1 and Mr Bayes phylogenetic tree in www.peroxisomeDB.org; Ref. 54) . Compared with model organisms such as yeasts, drosophila, or Caenorhabditis elegans, the mouse thus appears as a suitable model to resolve the biological function of ABCD1 and ABCD2.
Nonconserved domains between ABCD1 and ABCD2. The human ABCD1 and ABCD2 proteins share an overall 80% homology. The most conserved part encompasses the ABC domain (92% of homology), whereas the N-terminal part (1-496 in ABCD2), exhibits only 74% of homology (Supplemental Fig. 1 ). To get a better view on the nonconserved domains between ABCD1 and ABCD2, we performed a multialignment by CLUSTALW, excluding the ABC domain. This revealed three main nonconserved regions: 1) the largest region of divergence is located in the first 100 N-terminal residues; 2) the second region is encompassed between amino acids 380 and 395 with an extra motif for ABCD1; and 3) the third region is located between amino acids 460-480. Based on transmembrane predictors (see MATERIALS AND METHODS), these three regions should be located outside the intramembrane domains, suggesting involvement in the conformation of the ligand binding domain, and thus might account for substrate specificities between ABCD1 and ABCD2 (Supplemental Fig. 1) .
Changes in the fatty acid profile of the sciatic nerve, adrenal gland, and spinal cord from Abcd2 Ϫ/Ϫ and Abcd1
Ϫ/Ϫ mice. Fatty acids are delivered to the either complexed into lipoproteins or as nonesterified fatty acids, which enter the cells via fatty acid transporters (17) . Once in cells, the nonesterified fatty acids are rapidly converted to fatty acylCoA thioesters by acyl-CoA synthetases, specific for carbon length. Four types of fatty acids are most commonly found in tissues: saturated, 9 monounsaturated, and 3 and 6 PUFAs. We (46) Ϫ/Ϫ mice had normal levels of this fatty acid in the same organs. Interestingly, in the dorsal root ganglia, not Abcd1 mutants but Abcd2 accumulate C26:0 (12). This suggests that ABCD2 can carry out at least some of the function(s) assigned to ABCD1 without requiring overexpression, provided that its endogenous expression levels are high enough in the given organ or cell type. A cooperative function of both transporters could be seen in serum, because only double mutants significantly accumulated C26:0. A similar scenario applies to C24:0, which is found increased in spinal cords of double mutants only (46) . In contrast, the adrenal glands of Abcd2 Ϫ/Ϫ and double knockouts showed raised levels of C22:0, a metabolite never found increased in Abcd1 Ϫ mice (46) or X-ALD patients, indicating that deficiencies of either Abcd1 or Abcd2 are not equivalent if the metabolism of C22:0 is concerned. In the search for specific substrates putatively transported by ABCD2, we analyzed the total fatty acid profile in the adrenal gland, sciatic nerve, spinal cord, brain, and liver of the different mouse models (Abcd1
Ϫ/Ϫ , and wild-type controls) at 8 mo of age. It is worth noting that the analysis of total fatty acids encompasses the fatty acids found as lateral chains of complex lipids in membranes, the fatty acids as acyl-CoA esters, and the free fatty acids, the latter in little amounts. We have shown the altered profiles in Fig. 2 .
The obtained values are indicated as relative proportions of the specific fatty acids measured per tissue and also as nanomoles per milligrams of total lipids in Supplemental Table 1 as a reference. In addition to the above-mentioned changes in saturated VLCFAs, we also found an accumulation of C20:0 in the adrenal gland and sciatic nerves from Abcd2 Ϫ/Ϫ and Abcd1 Ϫ /Abcd2 Ϫ/Ϫ mice ( Fig. 2A) . Further, we detected increased levels of the 9-monounsaturated fatty acids C20:19 and C22:19 in sciatic nerves and adrenal gland from Abcd2 Ϫ/Ϫ and Abcd1 Ϫ /Abcd2 Ϫ/Ϫ mice (Fig. 2, B and C) . A marked increase of C22:19 level was also noticed in the spinal cord from Abcd1 Ϫ
/Abcd2
Ϫ/Ϫ mice (Fig. 2D) , although no alteration of any 9-monounsaturated fatty acids (MUFAs) could be observed in the brain or liver (not shown). Abcd1 Ϫ mice exhibited 9-MUFA levels similar to control mice. These results point to a specific role for ABCD2 in the metabolism of 9-MUFAs.
As peroxisomes play an indispensable function in the biosynthesis of the PUFAs DHA (C22:63) and DPA (C22:56), we analyzed long and very-long chain 3 and 6 PUFAs in the above-mentioned organs. We observed a decrease of C22:63 in the adrenal gland from Abcd1 Ϫ /Abcd2 Ϫ/Ϫ mice (Fig. 2E ). C22:56 levels were not affected in the whole organs of our mouse models (Fig. 2F ). As C22:56 is synthesized by ␤-oxidation of C24:56, the C22:56-to-0C22:46 ratio can be used as an indirect indicator of the C22:56 synthesis. Interestingly, the ratio C22:56 to C22:46 was decreased in tissues from Abcd1 Ϫ /Abcd2 Ϫ/Ϫ mice (Fig. 2G ). The chosen tissues for our analysis exhibit good expression levels of ABCD2 (28, 46) , and some display histopathological features, such as the adrenals, sciatic nerve, and spinal cord (35, 46) . Interestingly, the altered fatty acid profiles seem to correlate with the histopathologically or functionally altered tissues.
Accumulation of C20:0 and C22:0 in liver after feeding of a VLCFA-rich diet. We intended to add strength to our observations by means of a dietary challenge. Since mouse chow is known to contain low lipids levels, including the VLCFA species, we fed Abcd2 Ϫ/Ϫ mice a diet enriched in saturated fatty acids (hereafter called SAT-diet, containing a higher content of C20:0, C22:0, and C24:0, Supplemental Fig. 2 ). Because the fatty acid content of liver parenchyma is thought to be related to the exogenous source, we analyzed hepatic fatty acid levels from both SAT-diet and standard chow-fed Abcd2 Ϫ/Ϫ and control littermates. No differences were detected in the saturated fatty acid levels in the livers of 5-and 12-mo-old chow-fed Abcd2 Ϫ/Ϫ mice compared with wild-type mice (data not shown). In contrast, C20:0 and C22:0 levels were increased in the livers from Abcd2 Ϫ/Ϫ mice on a SAT- Fig. 2 . C20:0 levels in adrenal gland, sciatic nerve, and spinal cord from 8-mo-old wild-type (Wt), Abcd1 Ϫ , Abcd2 Ϫ/Ϫ , and Abcd1 Ϫ /Abcd2 Ϫ/Ϫ mice (A). 9-monounsaturated fatty acids levels in adrenal gland (B), in sciatic nerve (C), and in spinal cord (D) from 8-mo-old mice. C22:63 levels (E), C22:56 levels (F), and C22:56-to-C22:46 ratio (G) in adrenal gland, in sciatic nerve, and in spinal cord from 8-mo-old mice. Concentration of fatty acid in total tissue lipids is expressed as percentage of total fatty acids relative to Wt of 3-8 samples. For adrenal gland and sciatic nerve, a given value results from pooling the organs of 2-4 animals, respectively. A minimum of 3 independent pools were used for lipid analysis. Significant differences have been determined by ANOVA followed by Tukey's honestly significantly different (HSD) post hoc (*P Յ 0.05, **P Յ 0.01, and ***P Յ 0.001).
diet, reaching statistical significance at 12 mo (Fig. 3A) . C24:0 and C26:0 levels were raised as well, although not enough to be statistically different from controls. No effect of the diet was noticed on the 3-, 6-, or 9-fatty acid series; also, no additional differences were observed in the other organs analyzed.
ABCD2 plays a role in fatty acid catabolism during fasting. Fasting is a physiological stress condition that leads to lipolysis in adipose tissue and the release of free fatty acids into the circulation, which are subsequently taken up and degraded as an energy source in most organs. We investigated whether ABCD2 could have a functional role in fasting by first checking its expression levels. Interestingly, Abcd2 mRNA levels were increased 2.8-fold times in livers from mice fasted for 48h (Fig. 3B) . Knowing this, we hypothesized that the fatty acids transported via Abcd2 under normal conditions, would most likely accumulate in Abcd2 knockouts in a given situation that would require extra-work to be performed by Abcd2. We then fasted wild-type and Abcd2 Ϫ/Ϫ mice for 48h and quantified fatty acid levels in serum (Fig. 3C) . We noticed that C22:19 content was higher in Abcd2 Ϫ/Ϫ mice under basal and fasting conditions. Moreover, while levels of circulating C20:0 decreased in wild-type mice on fasting, most likely because of degradation in liver or adipose tissue obeying energetic requirements, in Abcd2 knockouts this was not the case. These results reinforce the notion that ABCD2 could be involved in the degradation of saturated VLCFAs and 9-MUFAs.
Changes in the fatty acid profile of primary hippocampalcortical culture from Abcd2
Ϫ/Ϫ and Abcd1 Ϫ/Ϫ /Abcd2 Ϫ/Ϫ mice. Because Abcd2 is highly expressed in mouse hippocampal and cortical neurons, particularly during differentiation in embryonic development (12, 62) , we investigated the fatty acid profile in hippocampal-cortical primary neurons from E16 mice embryos (Abcd1 , and Abcd1 Ϫ /Abcd2 Ϫ/Ϫ mice. To demonstrate directly a role of ABCD2 in the oxidation of VLCFAs and PUFAs, we performed ␤-oxidation assays with radiolabeled fatty acids as a measure of fatty acid transport across the peroxisomal membrane. We chose as a target tissue the brain cortex, which provides a sufficient amount of material and highly expressed Abcd2. To create conditions as close as possible to the in vivo situation, we used freshly chopped cortical brain slices from the different mouse models as starting material, and prepared cortical brain slices from 6-wk-old Abcd1 Ϫ , Abcd2 Ϫ/Ϫ , and Abcd1 Ϫ /Abcd2 Ϫ/Ϫ mice. As we needed an internal control to validate the experiment, we sought to test the capacity of Abcd1 Ϫ intact tissue to degradate C26:0, which we expected to be defective as is the case in human X-ALD fibroblasts (65) . We incubated cortical slices with 1-14 C-radiolabeled C26:0 during 3 h to demonstrate for the first time a marked impairment up to 50% of C26:0 ␤-oxidation in tissues from Abcd1 Ϫ mice. The same result holds true for Abcd2 Ϫ/Ϫ and Abcd1 Ϫ /Abcd2 Ϫ/Ϫ mice, as a further proof of functional redundancy between both transporters (Fig. 4B) . This functional assay confirms that the detected accumulation of C26:0 in the brain (Abcd1 Ϫ and Abcd1 Ϫ / Fig. 3 . Saturated fatty acid levels in liver from 5-and 12-mo-old Wt, Abcd2
Ϫ/Ϫ mice fed with saturated-diet (A). Analysis of Abcd2 Ϫ/Ϫ mice under fasting conditions. Abcd2 (Aldr) expression levels. Two and a half-month-old Wt mice (n ϭ 5) were fasted for 2 days and hepatic levels of Abcd2 were compared with those of fed animals (n ϭ 6) by quantative RT-PCR and normalized to 36b4 (B). C20:0 and C22:19 levels in serum from 2.5-mo old Abcd2 Ϫ/Ϫ (n ϭ 3) and Wt (n ϭ 6) mice fasted for 2 days compared with Abcd2 Ϫ/Ϫ (n ϭ 4) and Wt (n ϭ 6) fed mice (C). Significant differences have been determined by ANOVA followed by Tukey HSD post hoc (*P Յ 0.05, **P Յ 0.01, and ***P Յ 0.001).
Abcd2
Ϫ/Ϫ mice; Refs. 14, 36, 46) is indeed due to an impaired oxidation of this fatty acid. Next, we incubated the slices of the different mutants with 1-14 C-radiolabeled C24:63. We evidenced a 25% decrease in the capacity to ␤-oxidize C24:63 in Abcd2 Ϫ/Ϫ and Abcd1 Ϫ /Abcd2 Ϫ/Ϫ mice. Interestingly, we found no deficiency of C24:63 oxidation in Abcd1 Ϫ mice (Fig. 4B) . These results indicate a selective function of Abcd2 in the chain shortening of C24:63 or synthesis of DHA in the cortex, as the underlying reason for the lowered DHA levels found in primary neurons.
Lack of transcriptional effects on sterol regulatory element binding protein, peroxisome proliferator-activated receptor, liver X receptor-␣, or hepatocyte nuclear factor 4␣ target genes. Fatty acyl-CoAs are metabolized in many different metabolic pathways (␤-oxidation, elongation, desaturation, triglyceride or cholesterol synthesis, and prostanoid or leukotriene synthesis), where each intermediate metabolite or end product can be responsible for the transcriptional effect of LCFAs. For instance, it was shown that nonesterified fatty acids, long chain acyl-CoAs, lipooxygenase-derived metabolite leukotriene B4, prostacyclins, and 15-deoxy-12,14-prostaglandin J2 are potent regulators of transcription depending upon the gene considered and the cell-specific context; for general review see Refs. 34, 41. In particular, the manipulation of 3-PUFA and/or the ratio of 6-PUFA to 3-PUFA may influence the expression of many genes in the brain (52) . Specific PUFAs might act as ligands of several nuclear receptors, such as peroxisome proliferator-activated receptors-␣, -␤, and -␥ (PPARs), liver X receptor-␣ (LXR␣), hepatocyte nuclear factor 4␣ (HNF4␣), or as modulators of nuclear transcription factors such as sterol regulatory element binding protein (SREBP; Refs. 9, 23). To investigate whether disturbances in metabolic pathways controlled by these transcription factors might be affected in our mouse models, we analyzed the expression levels of selected target genes. We studied acyl-CoA oxidase (Acox1), fatty acid synthase (Fasn; Ref. Ϫ/Ϫ /Abcd2 Ϫ/Ϫ mice. We found no differences in the expression levels of the above-mentioned genes in any of the mutants (data not shown), which suggests that despite significant changes in the fatty acid profiles, transcriptional dysregulation of key genes in pathways controlled by SREBP, PPARs, LXR␣, and HNF4␣ does not occur.
DISCUSSION
We have previously shown a functional overlap between Abcd1 and Abcd2 peroxisomal transporters. Overexpression of Abcd2 is able to correct the defective catabolism of VLCFA in Abcd1 Ϫ mice and even to prevent the development of a late onset neurodegenerative phenotype caused by loss of function of Abcd1 (12, 46) . Phylogenetic analysis suggests that the divergence of ABCD1 and ABCD2 originated as the vertebrate lineage appeared. Both transporters are well conserved among all sequenced vertebrate genomes, strongly suggesting that (n ϭ 9) mice (A). ␤-oxidation assays in cortical brain slices from Wt, Abcd1 Ϫ , Abcd2 Ϫ/Ϫ , and Abcd1 Ϫ /Abcd2 Ϫ/Ϫ mice, for C26:0 and C24:63 radiolabeled fatty acids. Activity was expressed as nmol of radiolabeled acetate made in 1 h/mg protein. The ␤-oxidation value is expressed as percentage of activity relative to Wt of 4 to 8 samples per genotype, out of 3 independent experiments (B). Significant differences have been determined by ANOVA followed by Tukey HSD posttest (*P Յ 0.05, **P Յ 0.01, and ***P Յ 0.001).
they have kept specific substrates and functions. It is tantalizing to speculate that this divergence could represent a "gain of function," belonging to an integrated evolutionary program and necessary to allow the development of higher complexity systems, i.e, the nervous system of vertebrates, for which compounds such as DHA are of paramount importance. In search for ABCD2-specific roles, we set out to explore fatty acid profiles in the tissues of the three different mouse mutants and used dietary manipulation and fasting to give strength to our observations. We readily detected an accumulation of saturated C20:0 and 9-monounsaturated LCFAs in an ABCD2-dependent manner, indicating that this transporter is involved in the homeostasis of these fatt acids. Since the different ABCDs have been suggested to act as metabolite transporters, one simple explanation would be that Abcd2 either as homo-or heterodimer would catalyze the uptake of these fatty acids, as CoA-ester or otherwise, across the peroxisomal membrane. A diet enriched in saturated VLCFAs strengthened this defect as a function of time. Fasting is a metabolic stress condition that results in upregulation of Abcd2 expression; analysis of serum from Abcd2 Ϫ/Ϫ fasted mice therefore provided further evidence pointing to the impaired degradation of C20:0, most likely as a mirror of the situation in liver or white adipose tissue. Concerning the 9 series, our results are in agreement with other studies in humans, suggesting that erucic acid (22:19) degradation is preferentially peroxisomal (5, 7, 44) . Moreover, accumulation of C20:0, C20:19, C22:19, and C24:19 has been noticed in Zellweger fibroblasts (3) but not in X-ALD fibroblasts. This indicates that 9-monounsaturated VLCFA catabolism requires functional peroxisomes but is independent of Abcd1, at least in fibroblasts (3, 6) . In conclusion, our observations underline the role of peroxisomes in the degradation of saturated and 9-monounsaturated LCFAs and VLCFAs and uncover specific functions for Abcd2, distinct from its overlapping function with Abcd1. It is worth noting that in organs, such as adrenals and the sciatic nerve, Abcd1 seems to function in cooperation with Abcd2, resulting in significant increases of C22:19 when both transporters are missing. This is even clearer in the spinal cord, where only the inactivation of both transporters results in a significant increase of C22:19 levels, providing a strong indication of functional redundancy regarding this specific metabolite. This is also seen in neuronal cultures, where significantly increased levels of C20:19 are accumulated in double mutants only. This indicates that Abcd1 and Abcd2 can be functionally redundant for C22:19 and C20:19 in addition to C26:0 as formerly reported. The fact of having found specific accumulation of saturated and 9-monounsaturated long-and VLCFAs in the adrenal gland, spinal cord, or sciatic nerve of Abcd2 Ϫ/Ϫ mice, but not in other organs, might indicate that the physiological role of Abcd2 in these tissues is more important than, for instance, in the liver or brain or, alternatively, that loss of ABCD2 function in these particular organs or cell types is not compensated by any of the other members of the ABCD subfamily or by means of an alternative metabolic route.
We have also investigated another major function of peroxisomes: the biosynthesis of the PUFA DPA (C22:56) and DHA (C22: 63; Ref. 68) . In cultures derived from cortical neurons, where Abcd2 is highly expressed, we observed a 30% decrease of DHA and DPA levels, comparable with the decrease found in the brain of Pex5 Ϫ/Ϫ mice (22) and the brain of Zellweger patients, which are devoid of functional peroxisomes (37) . DHA is one of the major building structures of membrane phospholipids; its deficiency can prevent proper renewal of membranes and accelerate aging. DHA has been shown to exert positive effects on neuronal differentiation, function, and neurotransmission (4, 25, 26) . Given the low levels of DHA detected in our primary neuronal cultures, in-depth behavioral analysis directed at exploring higher cognitive functions of ABCD2 knockouts seems appropriate. Moreover, conclusive evidence for a role of Abcd2 in PUFA biosynthesis is provided by the reduced ␤-oxidation capability for C24:63, as seen in Abcd2 Ϫ/Ϫ and double Abcd2/Abcd1 knockout tissue. These results are in favor of a central role of Abcd2 in fatty acid homeostasis, most likely by acting in the uptake of the precursors C24:63 and C24:56 into the peroxisome.
Indeed, a major contribution of this work derives from the setup of the peroxisomal ␤-oxidation technique that allows ex vivo assessment of fatty acid oxidation in nervous tissue. Recent investigations (38) could not find alterations of the ␤-oxidation of C24:0 in any of the tissue homogenates from the X-ALD mouse model tested, which prompted the authors to argue against a role of Abcd1 in the degradation of VLCFA. It should be noted that the authors performed C24:0 ␤-oxidation assays using frozen postnuclear supernatants of tissue homogenates or purified peroxisomes from liver (19) , which may well account for the different experimental results, especially since the peroxisomal membrane is notoriously fragile upon isolation. If membrane integrity is disrupted, substrates for the peroxisomal ␤-oxidation system can freely reach their site of oxidation in contrast to the situation in intact cells or tissue, as shown in this work. This is supported by the observation that yeast lacking one or both ABCD paralogues (Pxa1p and Pxa2p) show elevated VLCFA levels and defective ␤-oxidation in intact cells, whereas oxidation is normal in cell lysates. Thus we convincingly show that Abcd1 and Abcd2 are required for correct peroxisomal ␤-oxidation of C26:0 and C24:63 in intact brain tissue.
Taking our findings together, we propose a model for the functioning of ABCD1 and ABCD2 in Fig. 5 . As discussed above, these roles are based on the following: 1) the deficiency of C26:0 and C24:63 ␤-oxidation, and 2) the changes in the fatty acid profile in tissues of mutant animals under basal or challenged conditions. Based on the overlapping functions of Abcd1 and Abcd2 and because deficiency of C26:0 and C24: 63 ␤-oxidation is only partial in the mutant mice studied, it seems plausible that the other members of the ABCD family (ABCD3 or ABCD4) might contribute to the remaining ␤-oxidation activity. To further clarify this issue, the same type of experiments should be repeated in single or double Abcd3 Ϫ/Ϫ / Abcd4 Ϫ/Ϫ /Abcd2 Ϫ/Ϫ mice once they become available. Nonetheless, definitive establishment of the role of ABCDs awaits successful reconstitution of ABCDs, either as homo-or heterodimers, into liposomes followed by in vitro transport studies. Very recently, significant advances in the field (15) may eventually help to circumvent the technical complexity associated with the approach and complete our understanding of ABCD roles in fatty acid transport.
To date, no human disease has been linked to the ABCD2 gene locus. Mice lacking Abcd2 exhibit hyperactivity, lateonset peripheral neuropathy, and spinocerebellar ataxia (12) , presumably as a consequence of the chronic disturbances of fatty acid metabolism as reported here. Our findings deliver specific profiles of altered fatty acids enhancing the previously described, rather broad phenotype, thus greatly facilitating associations of compatible phenotypes to the ABCD2 gene locus at 12q1.1-2. In analogy with X-ALD patients, in which we found a 4-to 10-fold accumulation of C26:0 in plasma, in spite of a milder accumulation of C26:0 in tissues and none in plasma in the Abcd1 knockout mice, we believe that patients with mutations in ABCD2 could present with lowered levels of C22:63 and C22:56 in plasma, mononuclear cells, or fibroblasts. The importance of our findings go well beyond the field of rare disease, as recent reports have demonstrated that lower levels of DHA in plasma or tissues are correlated with high risk for coronary heart disease (18) and Alzheimer's disease (53) . Moreover, low plasma levels of 6 and DHA fatty acids are associated with the accelerated decline of peripheral nerve function with aging (29) . This suggests that ABCD2 as peroxisome gate opener might well be a key player regulating DHA and DPA endogenous synthesis and, in view of the literature, a potential candidate modifier gene and/or modulating factor contributing to a growing list of common human disorders and aging.
